Amplification and Selection of Antimicrobial Resistance in the Intestine (ASARI)

University Hospital Tuebingen

Status: Completed

Conditions: Acute Leukaemia

Study type: Observational

Funder types: Other

Identifiers

NCT02058888

TTU 08.808

Details and patient eligibility

About

The worldwide increase in the incidence of multidrug-resistant (MDR) pathogens is alarming. Antimicrobial treatment is a risk factor for the isolation of MDR pathogens and can therefore contribute to the observed trend. Differences in the degree of selection pressure caused by various antimicrobials have not been systematically investigated until today. The aim of the proposed project is the determination of the impact of antibiotic treatment on the copy number of resistance genes in the human intestinal microbiome using metagenome shotgun sequencing. The resistance gene count in the gastrointestinal tract will be determined in a clinical cohorts of patients treated with either ciprofloxacin or cotrimoxazol as monotherapy. The subsequent quantification and comparison of the selection pressure facilitates the application of antibiotics with a lower potential to select for resistance. To achieve this goal, a self-controlled, prospective observational epidemiological study will be performed at two centres of the German Centre for Infection Research (Tübingen, Cologne).

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• male or female patients ≥ 18 years
• patients with acute leukaemia
• admission to one of the 2 study centres
• obtained written consent

Exclusion criteria

• treatment with antibiotics in the previous 30 days
• pregnancy
• patients currently treated for HIV and/or hepatitis b/c
• patients who can not estimate scope and consequences of their participation in the study
• patients who will most likely not be able to follow the study protocol